Evidence map›Paper›PMID 37789892›Full record

ArticleFrontiers in neurology2023

Altered gut microbiota and metabolites in untreated myasthenia gravis patients.

Xiao-Jun Ding, Hong-Yan Li, Huaiping Wang, Xue-Hua Zhang, Min Song, Xiao-Han Jiang, Xu Zhang, Yao-Xian Yue, Xiao-Hong Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiao-Jun DingDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Hong-Yan LiDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Huaiping WangDepartment of Geriatric Medicine, Qingdao Fuwai Cardiovascular Hospital, Qingdao, China.
Xue-Hua ZhangDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Min SongDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Xiao-Han JiangDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Xu ZhangDepartment of Clinical Psychology, Affiliated Hospital of Qingdao University, Qingdao, China.
Yao-Xian YueDepartment of Neurology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Xiao-Hong LiDepartment of Neurology, Jinan Central Hospital, Shandong University, Jinan, China.
Shandong University · CNAffiliated Hospital of Qingdao University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The homeostasis of the immune system is influenced by the gut microbiota. Previous studies have reported dysbiosis in the gut microbiota of myasthenia gravis (MG) patients. To investigate potential alterations in gut microbiota and metabolites in newly diagnosed and untreated MG patients, we conducted a case-control study. Methods: Fecal samples were collected from 11 newly diagnosed and untreated MG patients as well as 11 age-and sex-matched healthy controls. These samples underwent analysis for gut microbiota using 16S ribosomal RNA (rRNA) gene sequencing, while fecal metabolome was analyzed using liquid chromatography-electrospray tandem mass spectrometry system (LC-ESI-MS/MS). Results: The microbial community richness (observed species) and diversity (Shannon and Simpson indices) were significantly lower in the MG group compared to the control group. Microbiota composition analysis revealed significant differences between the MG and control groups at phylum, family, and genus levels. Linear discriminant analysis effect size (LEfSe) analysis showed a substantial decrease in abundance of the genus Conclusion: Our findings suggest that dysbiosis already exists in newly diagnosed and untreated MG patients, implying that dysbiosis within the gut microbiota may be an initiating factor contributing to MG pathogenesis. Furthermore,

Indexed as

16S rRNAFaecalibacteriumgut microbiotametabolitesmyasthenia gravis

Identifiers

PMID37789892
PMCPMC10542407
OpenAlexW4386836141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.